This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (37)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Alert me on articles by topic

Guna Raj, MD; Raminder Kumar, MD; W. Paul McKinney, MD

Arch Intern Med. 1999;159:2721-2724.

Background  Excessive anticoagulation increases the risk of hemorrhagic complications associated with oral anticoagulant therapy. Oral or parenteral phytonadione is used to reverse excessive anticoagulation. Intravenous (IV) phytonadione, while effective, is associated with a small risk of serious anaphylactic reactions. Subcutaneous (SC) administration is safer, but there is little information on its relative efficacy in small doses.

Methods  Twenty-two patients with asymptomatic prolongation of prothrombin time were prospectively randomized and treated with 1 mg of phytonadione IV or 1 mg SC. Prothrombin time was measured at baseline and at 8 and 24 hours after phytonadione administration and expressed as international normalized ratio (INR).

Results  Mean INR at baseline was 8.0 and 8.5 in the IV and SC groups, respectively (P = .70). At 8 hours, mean INR was 4.6 in the IV group and 8.0 in the SC group (P = .006), and at 24 hours, mean INR was 3.1 in the IV group and 5.0 in the SC group (P = .009). Mean decrease in INR 8 hours after administration of phytonadione was 3.4 in the IV group and 0.4 in the SC group (P = .02), and mean decrease in INR after 24 hours was 4.9 in the IV group and 3.4 in the SC group (P = .18).

Conclusions  For patients who are excessively anticoagulated with warfarin, small doses of SC phytonadione may not correct the INR as rapidly or as effectively as when administered IV. Higher doses must be considered for more rapid and complete reversal of anticoagulation by the SC route.

From the Section of General Internal Medicine, Dallas Veterans Affairs Medical Center, and Department of Medicine, University of Texas Southwestern Medical Center, Dallas (Drs Raj and Kumar); and Division of General Internal Medicine, University of Louisville, Louisville, Ky (Dr McKinney).

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(22):2751.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Ansell et al.
Chest 2008;133:160S-198S.
ABSTRACT | FULL TEXT  

REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Circulation 2007;116:e391-e413.
ABSTRACT | FULL TEXT  

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Stroke 2007;38:2001-2023.
ABSTRACT | FULL TEXT  

Antidote use in the critically ill poisoned patient.
Betten et al.
J Intensive Care Med 2006;21:255-277.
ABSTRACT  

Treatment of Excessive Anticoagulation With Phytonadione (Vitamin K): A Meta-analysis.
DeZee et al.
Arch Intern Med 2006;166:391-397.
ABSTRACT | FULL TEXT  

Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage
Goldstein et al.
Stroke 2006;37:151-155.
ABSTRACT | FULL TEXT  

Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions
Steiner et al.
Stroke 2006;37:256-262.
ABSTRACT | FULL TEXT  

Managing Complications of Anticoagulant Therapy
Smythe et al.
Journal of Pharmacy Practice 2004;17:327-346.
ABSTRACT  

Management of Bleeding in Patients with Advanced Cancer
Pereira and Phan
The Oncologist 2004;9:561-570.
ABSTRACT | FULL TEXT  

The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT | FULL TEXT  

Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review
Wilson et al.
CMAJ 2004;170:821-824.
ABSTRACT | FULL TEXT  

Oral Vitamin K for Warfarin-Associated Coagulopathy
Weideman and Patel
ANN INTERN MED 2003;138:610-610.
FULL TEXT  

A Survey of Oral Vitamin K Use by Anticoagulation Clinics
Libby and Garcia
Arch Intern Med 2002;162:1893-1896.
ABSTRACT | FULL TEXT  

Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy: A Randomized, Controlled Trial
Crowther et al.
ANN INTERN MED 2002;137:251-254.
ABSTRACT | FULL TEXT  

Treatment of Warfarin-Associated Coagulopathy : A Physician Survey
Wilson et al.
Chest 2001;120:1972-1976.
ABSTRACT | FULL TEXT  

Anticoagulation Therapy
Ginsberg et al.
ASH Education Book 2001;2001:339-357.
ABSTRACT | FULL TEXT  

Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119:22S-38S.
FULL TEXT